BACKGROUND/ OBJECTIVES: Insufficient blood supply to the heart results in ischemic injury manifested clinically as myocardial infarction (MI). Following ischemia, inflammation is provoked and related to the clinical outcomes. A recent basic science study indicates that complement factor MASP-2 plays an important role in animal models of ischemia/reperfusion injury. We investigated the role of MASP-2 in human acute myocardial ischemia in two clinical settings: (1) Acute MI, and (2) Open heart surgery. METHODS: A total of 187 human subjects were enrolled in this study, including 50 healthy individuals, 27 patients who were diagnosed of coronary artery disease (CAD) but without acute MI, 29 patients with acute MI referred for coronary angiography, and 81 cardiac surgery patients with surgically-induced global heart ischemia. Circulating MASP-2 levels were measured by ELISA. RESULTS: MASP-2 levels in the peripheral circulation were significantly reduced in MI patients compared with those of healthy individuals or of CAD patients without acute MI. The hypothesis that MASP-2 was activated during acute myocardial ischemia was evaluated in cardiac patients undergoing surgically-induced global heart ischemia. MASP-2 was found to be significantly reduced in the coronary circulation of such patients, and the reduction of MASP-2 levels correlated independently with the increase of the myocardial necrosis marker, cardiac troponin I. CONCLUSIONS: These results indicate an involvement of MASP-2 in ischemia-related necrotic myocardial injury in humans.
BACKGROUND/ OBJECTIVES: Insufficient blood supply to the heart results in ischemic injury manifested clinically as myocardial infarction (MI). Following ischemia, inflammation is provoked and related to the clinical outcomes. A recent basic science study indicates that complement factor MASP-2 plays an important role in animal models of ischemia/reperfusion injury. We investigated the role of MASP-2 in human acute myocardial ischemia in two clinical settings: (1) Acute MI, and (2) Open heart surgery. METHODS: A total of 187 human subjects were enrolled in this study, including 50 healthy individuals, 27 patients who were diagnosed of coronary artery disease (CAD) but without acute MI, 29 patients with acute MI referred for coronary angiography, and 81 cardiac surgery patients with surgically-induced global heart ischemia. Circulating MASP-2 levels were measured by ELISA. RESULTS:MASP-2 levels in the peripheral circulation were significantly reduced in MI patients compared with those of healthy individuals or of CAD patients without acute MI. The hypothesis that MASP-2 was activated during acute myocardial ischemia was evaluated in cardiac patients undergoing surgically-induced global heart ischemia. MASP-2 was found to be significantly reduced in the coronary circulation of such patients, and the reduction of MASP-2 levels correlated independently with the increase of the myocardial necrosis marker, cardiac troponin I. CONCLUSIONS: These results indicate an involvement of MASP-2 in ischemia-related necrotic myocardial injury in humans.
Authors: Todd K Rosengart; Eileen B Finnin; David Y Kim; Sanjay A Samy; Yvette Tanhehco; Wilson Ko; Samuel J Lang; Karl H Krieger; O Wayne Isom Journal: Am J Med Date: 2002-02-01 Impact factor: 4.965
Authors: N Greenson; J Macoviak; P Krishnaswamy; R Morrisey; C James; P Clopton; R Fitzgerald; A S Maisel Journal: Am Heart J Date: 2001-03 Impact factor: 4.749
Authors: Akif Undar; Harald C Eichstaedt; Fred J Clubb; Michael Fung; Meisheng Lu; Joyce E Bigley; William K Vaughn; Charles D Fraser Journal: Ann Thorac Surg Date: 2002-08 Impact factor: 4.330
Authors: Anja Roos; Lee H Bouwman; Jeric Munoz; Tahlita Zuiverloon; Maria C Faber-Krol; Francien C Fallaux-van den Houten; Ngaisah Klar-Mohamad; C Erik Hack; Marcel G Tilanus; Mohamed R Daha Journal: Mol Immunol Date: 2003-01 Impact factor: 4.407
Authors: Wilhelm J Schwaeble; Nicholas J Lynch; James E Clark; Michael Marber; Nilesh J Samani; Youssif Mohammed Ali; Thomas Dudler; Brian Parent; Karl Lhotta; Russell Wallis; Conrad A Farrar; Steven Sacks; Haekyung Lee; Ming Zhang; Daisuke Iwaki; Minoru Takahashi; Teizo Fujita; Clark E Tedford; Cordula M Stover Journal: Proc Natl Acad Sci U S A Date: 2011-04-18 Impact factor: 11.205
Authors: C B Holt; J A Østergaard; S Thiel; T K Hansen; L Mellbin; P Sörensson; M Bjerre Journal: Clin Exp Immunol Date: 2019-06-03 Impact factor: 4.330
Authors: V Frauenknecht; S Thiel; L Storm; N Meier; M Arnold; J-P Schmid; H Saner; V Schroeder Journal: Clin Exp Immunol Date: 2013-07 Impact factor: 4.330
Authors: Isabela Goeldner; Thelma Skare; Angelica B W Boldt; Flavia R Nass; Iara J Messias-Reason; Shirley R Utiyama Journal: PLoS One Date: 2014-03-14 Impact factor: 3.240
Authors: Nicholas Chun; Ala S Haddadin; Junying Liu; Yunfang Hou; Karen A Wong; Daniel Lee; Julie I Rushbrook; Karan Gulaya; Roberta Hines; Tamika Hollis; Beatriz Nistal Nuno; Abeel A Mangi; Sabet Hashim; Marcela Pekna; Amy Catalfamo; Hsiao-Ying Chin; Foramben Patel; Sravani Rayala; Ketan Shevde; Peter S Heeger; Ming Zhang Journal: PLoS One Date: 2017-06-29 Impact factor: 3.240